METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) AS A CAUSE OF NOSOCOMIAL WOUND INFECTIONS

被引:33
|
作者
Sisirak, Maida [1 ]
Zvizdic, Amra [1 ]
Hukic, Mirsada [1 ]
机构
[1] Univ Sarajevo, Inst Clin Microbiol, Ctr Clin, Sarajevo 71000, Bosnia & Herceg
关键词
MRSA; hospital infections; surgical wound; VANCOMYCIN; EPIDEMIOLOGY;
D O I
10.17305/bjbms.2010.2733
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Postoperative wound infections represent about 16% of hospital-acquired infections. Staphylococcus aureus is the most common cause of nosocomial wound infections. Increased frequency of Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized patients and possibility of vancomycin resistance requires permanent control of MRSA spread in the hospital. The purpose of this study was to analyse the frequency of Methicillin-resistant Staphylococcus aureus (MRSA) in the swabs taken from the surgical wounds, the presence of MRSA infection in surgical departments and to examine antimicrobial susceptibility of MRSA isolates. Wound swabs were examined from January 2006 to December 2008. The isolates were identified by conventional methods. Antimicrobial susceptibility testing was performed by Kirby-Bauer disc-diffusion method as per NCCLS guidelines. A total Of 5755 wound swabs were examined: 938 (16,3%) swabs were sterile and 4817 (83,7%) were positive. Staphylococcus aureus was isolated in 1050 (22,0%) swabs and it was the most common cause of wound infections. MRSA was isolated from 12,4% samples in 2006, from 6,7% samples in 2007 and from 3,7% samples during 2008. Wound infections caused by MRSA dominated in the department of plastic surgery (244%) and in the department of orthopaedic surgery (24,1%). Antimicrobial susceptibility testing showed that 73% of MRSA isolates were with the same antibiotic sensitivity pattern (antibiotyp)-sensitive only to vancomycin, tetracycline, fucid acid and trimethoprim/sulfamethoxasole. Our results show decreasing of MRSA infection in the surgical wards. These results appear to be maintained with strategies for preventing nosocomial infection: permanent education, strong application of protocols and urging the implementation of strict infection control policy.
引用
下载
收藏
页码:32 / 37
页数:6
相关论文
共 50 条
  • [1] EPIDEMIOLOGY OF NOSOCOMIAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) INFECTIONS
    Turgut, Huseyin
    Sacar, Suzan
    Sungurtekin, Hulya
    Toprak, Semra
    Asan, Ali
    Tefci, Fatma
    Tekin, Koray
    NOBEL MEDICUS, 2005, 1 (03): : 7 - 10
  • [2] Reducing Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
    Griffin, Frances A.
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2007, 33 (12): : 726 - 731
  • [3] Methicillin-Resistant Staphylococcus aureus (MRSA)
    Randolph, Susan A.
    WORKPLACE HEALTH & SAFETY, 2012, 60 (03) : 136 - 136
  • [4] TOURNIQUETS AND NOSOCOMIAL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTIONS
    BERMAN, DS
    SCHAEFLER, S
    SIMBERKOFF, MS
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (08): : 514 - 515
  • [5] Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization
    Terushkin, Vitaly
    Brownell, Isaac
    JOURNAL OF DRUGS IN DERMATOLOGY, 2008, 7 (06) : 597 - 601
  • [6] Do glycopeptides still constitute the reference treatment for nosocomial MRSA infections (methicillin-resistant staphylococcus aureus infections)
    Brun-Buisson, C
    MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 : S184 - S187
  • [7] Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management
    Simonetti, Oriana
    Marasca, Samuele
    Candelora, Matteo
    Rizzetto, Giulio
    Radi, Giulia
    Molinelli, Elisa
    Brescini, Lucia
    Cirioni, Oscar
    Offidani, Annamaria
    AIMS MICROBIOLOGY, 2022, 8 (02): : 125 - 137
  • [8] Current methodologies on genotyping for nosocomial pathogen methicillin-resistant Staphylococcus aureus (MRSA)
    Miao, Jian
    Chen, Lequn
    Wang, Jingwen
    Wang, Wenxin
    Chen, Dingqiang
    Li, Lin
    Li, Bing
    Deng, Yang
    Xu, Zhenbo
    MICROBIAL PATHOGENESIS, 2017, 107 : 17 - 28
  • [9] Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
    Hooper, Candace Y.
    Smith, Winter J.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 131 - 137
  • [10] Methicillin-resistant Staphylococcus aureus (MRSA).: The prototype of a nosocomial multiresistant infectiour pathogen
    Linde, HJ
    Lehn, N
    HAUTARZT, 2002, 53 (10): : 690 - 699